Survey finds that people with chronic pain were more supportive of the policies that would expand access to medical cannabis.

PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...

Jeffrey Dunn, Pharm.D., MBA, discusses how social determinants of health and population health factors are integrated into decision-making processes for fertility treatments and assisted reproductive ...

A medical expert in infertility discusses how best practices in communicating benefits for fertility treatments and assisted reproductive technology (ART) programs involve clear, concise and ...

The IQVIA analysis finds that the impact of drug price negotiation on patients’ out-of-pocket spending could also be smaller ...

One area of interest is whether ketogenic diets, which are high in fat and low in carbohydrates, might be helpful to people ...

In an effort to promote research that would help fill this gap, the National Multiple Sclerosis Society has dedicated $4.6 ...

The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Bayer announced today that the FDA has accepted their new drug application (NDA) for menopause drug, elinzanetant, to treat ...

Studies measuring patient preference stacked up in subcutaneous administration’s favor, according to a recently published ...

The results showed that 26% of patients who received tulisokibart achieved clinical remission at week 12 compared with 1% of ...